CellWell record HH-534661
Combining Cystatin C and Creatinine Increases eGFR Slope Accuracy in ADPKD
Thomas Bais; Abdulfataah A A Mohamed; A Noruzi; Muhammad Umar; Bella A Binoy; M Salih; Esther Meijer; Ron T Gansevoort
2026
In plain language
In 260 patients with ADPKD, combined creatinine-cystatin C eGFR slopes correlated more strongly with measured GFR decline than creatinine-based slopes and reduced slope variability, lowering trial sample size needs by 37% to 38%.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-534661
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.